Marina White1, Ute D Feucht2,3,4, Eleanor Duffley1, Felicia Molokoane3,4,5, Chrisna Durandt6,7, Edana Cassol1, Theresa Rossouw7, Kristin L Connor8. 1. Department of Health Sciences, Carleton University, Ottawa, ON, K1S 5B6, Canada. 2. Paediatrics, University of Pretoria, Pretoria, GP 0002, South Africa. 3. Research Centre for Maternal, Fetal, Newborn & Child Health Care Strategies, University of Pretoria, Pretoria, GP 0002, South Africa. 4. Maternal and Infant Health Care Strategies Unit, South African Medical Council, Pretoria, South Africa. 5. Obstetrics and Gynaecology, University of Pretoria, Pretoria, GP, 0002, South Africa. 6. South African Medical Research Council Extramural Unit for Stem Cell Research and Therapy, University of Pretoria, Pretoria, GP 0002, South Africa. 7. Institute for Cellular and Molecular Medicine, Department of Immunology, University of Pretoria, Pretoria, GP 0002, South Africa. 8. Department of Health Sciences, Carleton University, Ottawa, ON, K1S 5B6, Canada. kristin.connor@carleton.ca.
Abstract
BACKGROUND: As mother-to-child transmission of HIV decreases, and the population of infants who are born HIV-exposed, but uninfected (HEU) continues to rise, there is a growing need to understand the development and health outcomes of infants who are HEU to ensure that they have the healthiest start to life. METHODS: In a prospective cohort pilot study at Kalafong Hospital, Pretoria, South Africa, we aimed to determine if we could recruit new mothers living with HIV on antiretrovirals (ART; n = 20) and not on ART (n = 20) and new mothers without HIV (n = 20) through our clinics to study the effects of HEU on growth and immune- and neurodevelopment in infants in early life, and test the hypothesis that infants who were HEU would have poorer health outcomes compared to infants who were HIV-unexposed, uninfected (HUU). We also undertook exploratory analyses to investigate relationships between the early nutritional environment, food insecurity and infant development. Infant growth, neurodevelopment (Guide for Monitoring Child Development [GMCD]) and levels of monocyte subsets (CD14, CD16 and CCR2 expression [flow cytometry]) were measured in infants at birth and 12 weeks (range 8-16 weeks). RESULTS: We recruited 33 women living with HIV on ART and 22 women living without HIV within 4 days of delivery from June to December 2016. Twenty-one women living with HIV and 10 without HIV returned for a follow-up appointment at 12 weeks postpartum. The high mobility of this population presented major challenges to participant retention. Preliminary analyses revealed lower head circumference and elevated CCR2+ (% and median fluorescence intensity) on monocytes at birth among infants who were HEU compared to HUU. Maternal reports of food insecurity were associated with lower maternal nutrient intakes at 12 weeks postpartum and increased risk of stunting at birth for infants who were HEU, but not infants who were HUU. CONCLUSIONS: Our small feasibility pilot study suggests that HEU may adversely affect infant development, and further, infants who are HEU may be even more vulnerable to the programming effects of suboptimal nutrition in utero and postnatally. This pilot and preliminary analyses have been used to inform our research questions and protocol in our ongoing, full-scale study.
BACKGROUND: As mother-to-child transmission of HIV decreases, and the population of infants who are born HIV-exposed, but uninfected (HEU) continues to rise, there is a growing need to understand the development and health outcomes of infants who are HEU to ensure that they have the healthiest start to life. METHODS: In a prospective cohort pilot study at Kalafong Hospital, Pretoria, South Africa, we aimed to determine if we could recruit new mothers living with HIV on antiretrovirals (ART; n = 20) and not on ART (n = 20) and new mothers without HIV (n = 20) through our clinics to study the effects of HEU on growth and immune- and neurodevelopment in infants in early life, and test the hypothesis that infants who were HEU would have poorer health outcomes compared to infants who were HIV-unexposed, uninfected (HUU). We also undertook exploratory analyses to investigate relationships between the early nutritional environment, food insecurity and infant development. Infant growth, neurodevelopment (Guide for Monitoring Child Development [GMCD]) and levels of monocyte subsets (CD14, CD16 and CCR2 expression [flow cytometry]) were measured in infants at birth and 12 weeks (range 8-16 weeks). RESULTS: We recruited 33 women living with HIV on ART and 22 women living without HIV within 4 days of delivery from June to December 2016. Twenty-one women living with HIV and 10 without HIV returned for a follow-up appointment at 12 weeks postpartum. The high mobility of this population presented major challenges to participant retention. Preliminary analyses revealed lower head circumference and elevated CCR2+ (% and median fluorescence intensity) on monocytes at birth among infants who were HEU compared to HUU. Maternal reports of food insecurity were associated with lower maternal nutrient intakes at 12 weeks postpartum and increased risk of stunting at birth for infants who were HEU, but not infants who were HUU. CONCLUSIONS: Our small feasibility pilot study suggests that HEU may adversely affect infant development, and further, infants who are HEU may be even more vulnerable to the programming effects of suboptimal nutrition in utero and postnatally. This pilot and preliminary analyses have been used to inform our research questions and protocol in our ongoing, full-scale study.
Entities:
Keywords:
Food security; Growth; HIV; Inflammation; Neurodevelopment; Nutrition; Pilot study
Authors: Nigel C Rollins; Hoosen M Coovadia; Ruth M Bland; Anna Coutsoudis; Michael L Bennish; Deven Patel; Marie-Louise Newell Journal: J Acquir Immune Defic Syndr Date: 2007-03-01 Impact factor: 3.731
Authors: D Drotar; K Olness; M Wiznitzer; C Schatschneider; L Marum; L Guay; J Fagan; D Hom; G Svilar; C Ndugwa; R K Mayengo Journal: Health Psychol Date: 1999-03 Impact factor: 4.267
Authors: Deanna Saylor; Alex M Dickens; Ned Sacktor; Norman Haughey; Barbara Slusher; Mikhail Pletnikov; Joseph L Mankowski; Amanda Brown; David J Volsky; Justin C McArthur Journal: Nat Rev Neurol Date: 2016-03-11 Impact factor: 42.937
Authors: Michal A Elovitz; Amy G Brown; Kelsey Breen; Lauren Anton; Monique Maubert; Irina Burd Journal: Int J Dev Neurosci Date: 2011-03-04 Impact factor: 2.457
Authors: Nicholas T Funderburg; David A Zidar; Carey Shive; Anthony Lioi; Joseph Mudd; Laura W Musselwhite; Daniel I Simon; Marco A Costa; Benigno Rodriguez; Scott F Sieg; Michael M Lederman Journal: Blood Date: 2012-10-11 Impact factor: 22.113
Authors: Diana M Gibb; Hilda Kizito; Elizabeth C Russell; Ennie Chidziva; Eva Zalwango; Ruth Nalumenya; Moira Spyer; Dinah Tumukunde; Kusum Nathoo; Paula Munderi; Hope Kyomugisha; James Hakim; Heiner Grosskurth; Charles F Gilks; A Sarah Walker; Phillipa Musoke Journal: PLoS Med Date: 2012-05-15 Impact factor: 11.069
Authors: Monray E Williams; Anicia Janse Van Rensburg; Du Toit Loots; Petrus J W Naudé; Shayne Mason Journal: Viruses Date: 2021-12-18 Impact factor: 5.048
Authors: Shamsudeen Mohammed; Laura L Oakley; Milly Marston; Judith R Glynn; Clara Calvert Journal: J Glob Health Date: 2022-09-03 Impact factor: 7.664